Return to Home Incidence > Table > Interpret

Interpretation of Incidence Rates Data

Incidence Rate Report by State

Cervix (All Stages^), 2017-2021

All Races (includes Hispanic), Female, All Ages

Sorted by Count

Explanation of Column Headers

Objective - The objective of *** is from the Healthy People 2020 project done by the Centers for Disease Control and Prevention.

Incidence Rate (95% Confidence Interval) - The incidence rate is based upon 100,000 people and is an annual rate (or average annual rate) based on the time period indicated. Rates are age-adjusted by 5-year age groups to the 2000 U.S. standard million population.

Recent Trends - This is an interpretation of the AAPC/APC:

AAPC/APC (95% Confidence Interval) - the change in rate over time


Other Notes


Line by Line Interpretation of the Report


US (SEER+NPCR)1


California7


Texas7


Florida6


New York7


Illinois7


Pennsylvania6


Ohio6


Georgia7


North Carolina6


New Jersey7


Michigan6


Tennessee6


Virginia6


Missouri6


Washington5


Alabama6


Arizona6


Kentucky7


Louisiana7


Maryland6


South Carolina6


Oklahoma6


Puerto Rico6


Massachusetts7


Colorado6


Wisconsin6


Minnesota6


Oregon6


Arkansas6


Mississippi6


Nevada6


Iowa7


Kansas6


Connecticut7


West Virginia6


Utah7


New Mexico7


Nebraska6


Idaho7


Hawaii7


Maine6


Delaware6


New Hampshire6


Rhode Island6


Montana6


District of Columbia6


South Dakota6


Wyoming6


Alaska6


North Dakota6


Vermont6


Indiana6

Notes:
Created by statecancerprofiles.cancer.gov on 10/03/2024 6:34 am.

State Cancer Registries may provide more current or more local data.

Data cannot be shown for the following areas. For more information on what areas are suppressed or not available, please refer to the table.
Indiana

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.
Rates and trends are computed using different standards for malignancy. For more information see malignant.html.

^ All Stages refers to any stage in the Surveillance, Epidemiology, and End Results (SEER) Summary/Historic Combined Summary Stage (2004+).
⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

* Data has been suppressed to ensure confidentiality and stability of rate estimates. Counts are suppressed if fewer than 16 records were reported in a specific area-sex-race category.
Data not available for this combination of data selections.
Source: SEER and NPCR data. For more specific information please see the table.

Data for the United States does not include data from Indiana.
Data for the United States does not include Puerto Rico.
CI*Rank data for Puerto Rico is not available.